Endo Pharmaceuticals, and Penwest Pharmaceuticals announced today that the companies have settled litigation with Actavis South Atlantic LLC regarding the production and sale of generic formulations of Opana ER (oxymorphone hydrochloride) Extended Release Tablets CII.
The details can be read here.
No comments:
Post a Comment